Jafron Biomedical Co.,Ltd. (300529.SZ)

CNY 30.04

(-0.07%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 5.54 Billion 5.41 Billion 4.81 Billion 3.21 Billion 2.49 Billion 2.05 Billion
Total Current Assets 3.31 Billion 3.29 Billion 3.05 Billion 1.98 Billion 1.55 Billion 1.3 Billion
Cash And Short Term Investments 2.81 Billion 2.55 Billion 2.46 Billion 1.57 Billion 1.27 Billion 1.08 Billion
Cash and Cash Equivalents 2.81 Billion 2.55 Billion 2.31 Billion 1.57 Billion 1.27 Billion 1.08 Billion
Short Term Investments -94.86 Million - 150.01 Million -20.41 Million -14.81 Million -3.36 Million
Net Receivables 99.29 Million 349.71 Million 377.5 Million 275.96 Million 194.2 Million 162.32 Million
Inventory 384.99 Million 349.12 Million 196.54 Million 120.67 Million 92.31 Million 61.15 Million
Other Current Assets 17.25 Million 35.64 Million 12.13 Million 14.92 Million 1.49 Million 955.65 Thousand
Total Non-Current Assets 2.23 Billion 2.12 Billion 1.75 Billion 1.23 Billion 934.91 Million 746.71 Million
Net PPE 1.77 Billion 1.67 Billion 1.27 Billion 905.5 Million 639.62 Million 457.63 Million
Good Will And Intangible Assets 112.57 Million 138.24 Million 145.38 Million 133.95 Million 92.12 Million 90.65 Million
Good Will 12.2 Million 37.81 Million 44.07 Million 44.07 Million 44.07 Million 44.07 Million
Intangible Assets 100.36 Million 100.43 Million 101.31 Million 89.88 Million 48.05 Million 46.58 Million
Long-Term Investments 210.99 Million 69.44 Million -38.81 Million 119.4 Million 115.6 Million 93.92 Million
Tax Assets 30.34 Million 33.36 Million 26.54 Million 12.97 Million 10.06 Million 7.13 Million
Other Non Current Assets 106.98 Million 207.21 Million 348.8 Million 58.21 Million 77.49 Million 97.35 Million
Other Assets 1.00 - - - - 1.00
Total Liabilities 2.39 Billion 1.82 Billion 1.42 Billion 383.06 Million 324.12 Million 330.04 Million
Total Current Liabilities 829.42 Million 717.18 Million 386.25 Million 330.81 Million 262.63 Million 278.89 Million
Account Payables 135.62 Million 128.52 Million 60.75 Million 50.21 Million 32.83 Million 29.89 Million
Tax Payables 57.4 Million 51 Million 105.69 Million 95.89 Million 41.51 Million 41.05 Million
Short Term Debt 282.45 Million 321.81 Million 3.17 Million 18.47 Million 59.65 Million 107.17 Million
Deferred Revenue 406.46 Million 42.29 Million 319.94 Million 26.94 Million 7.38 Million 2.49 Million
Other Current Liabilities 4.86 Million 224.54 Million 2.37 Million 235.17 Million 162.76 Million 139.33 Million
Total Non Current Liabilities 1.56 Billion 1.1 Billion 1.04 Billion 52.24 Million 61.49 Million 51.14 Million
Long-Term Debt 1.39 Billion 954.12 Million 914.38 Million 11.76 Million - -
Deferred Revenue Non Current 151.78 Million 151.65 Million 125.08 Million 51.69 Million 60.67 Million 51.14 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - -936.78 Million 1.00 -11.76 Million 1.00 -584.23 Thousand
Other Liabilities 1.00 - - - - -
Total Equity 3.15 Billion 3.59 Billion 3.38 Billion 2.83 Billion 2.17 Billion 1.72 Billion
Stock Holders Equity 3.14 Billion 3.57 Billion 3.35 Billion 2.8 Billion 2.14 Billion 1.69 Billion
Common Stock 807.55 Million 807.71 Million 805.49 Million 799.1 Million 418.66 Million 417.27 Million
Retained Earnings 2 Billion 2.1 Billion 1.93 Billion 1.36 Billion 958.67 Million 696.61 Million
Accumulated other comprehensive income 550.71 Million -5 Million 30.59 Million 330.96 Million 185.25 Million 65.97 Million
Common Stock Equity 3.14 Billion 3.57 Billion 3.35 Billion 2.8 Billion 2.14 Billion 1.69 Billion
Capital Lease Obligation 11.34 Million 17.34 Million 17.01 Million 11.76 Million - -
Total Investments 116.12 Million 69.44 Million 111.2 Million 98.98 Million 100.78 Million 90.56 Million
Total Debt 1.67 Billion 1.27 Billion 917.55 Million 30.23 Million 59.65 Million 107.17 Million
Net Debt -1.13 Billion -1.28 Billion -1.4 Billion -1.54 Billion -1.21 Billion -973.63 Million

Balance Sheet Charts